Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - human blood coagulation factor viii - injection, powder, for solution - 250 iu/vial - human blood coagulation factor viii 250 iu/vial

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - human coagulation factor viii - injection, powder, lyophilized, for solution - 500iu/vial - human coagulation factor viii 500iu/vial

Malta - English - Medicines Authority

baxter healthcare limited - octocog alfa 25 iu/ml - powder and solvent for solution for injection

Malta - English - Medicines Authority

baxter healthcare limited - octocog alfa 500 iu - powder and solvent for solution for injection

Malta - English - Medicines Authority

baxter healthcare limited - octocog alfa 1000 iu - powder and solvent for solution for injection

European Union - English - EMA (European Medicines Agency)

pfizer europe ma eeig - moroctocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor-viii deficiency). refacto af is appropriate for use in adults and children of all ages, including newborns. refacto af does not contain von-willebrand factor, and hence is not indicated in von-willebrand's disease.,

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - human coagulation factor viii - injection, powder, lyophilized, for solution - human coagulation factor viii 1000 iu/vial

European Union - English - EMA (European Medicines Agency)

bayer ag  - octocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor-viii deficiency).this preparation does not contain von willebrand factor and is therefore not indicated in von willebrand's disease.

Israel - English - Ministry of Health

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 250 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a .fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

Israel - English - Ministry of Health

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 500 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.